Stocktoria
Chemours Co CC
NYSE · XNYS · stock · Chemicals & Allied Products · website · IPO 2015-06-19
Chart by TradingView
4/9
Piotroski F — financial health
—
Altman Z″ — distress risk
-20.2%
Dividend payout · safe
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $5.8B | $5.8B | $6.1B | $6.8B | $6.3B |
| Gross profit | $902.0M | $1.1B | $1.3B | $1.6B | $1.4B |
| Net income | -$386.0M | $69.0M | -$253.0M | $578.0M | $608.0M |
| Operating cash flow | $264.0M | -$633.0M | $556.0M | $755.0M | $814.0M |
| Free cash flow | $51.0M | -$993.0M | $186.0M | $448.0M | $537.0M |
| Total assets | $7.4B | $7.5B | $8.2B | $7.6B | $7.5B |
| Total liabilities | $7.1B | $6.9B | $7.5B | $6.5B | $6.5B |
| Shareholders' equity | $251.0M | $572.0M | $723.0M | $1.1B | $1.1B |
| Ratios | |||||
| Gross margin | 15.5% | 19.8% | 21.4% | 23.7% | 21.8% |
| Net margin | -6.6% | 1.2% | -4.2% | 8.5% | 9.6% |
| FCF margin | 0.9% | -17.2% | 3.1% | 6.6% | 8.5% |
| Return on assets | -5.2% | 0.9% | -3.1% | 7.6% | 8.1% |
| Return on equity | -153.8% | 12.1% | -35.0% | 52.3% | 56.2% |
| Debt / equity | 16.33× | 7.10× | 5.52× | 3.25× | 3.44× |
| Current ratio | 1.78 | 1.66 | 1.55 | 1.70 | 1.80 |
| Revenue growth | 0.4% | -4.9% | -11.0% | 7.7% | 27.7% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 937,971 | $20.7M |
| Bridgewater Associates, LP | 149,257 | $3.3M |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001627223 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.